Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The PDCD6IP divergent transcript (PDCD6IP-DT) is a non-coding RNA gene observed at the PDCD6IP locus on chromosome 3. There is minimal published functional or mechanistic information about this transcript, and it does not encode a protein nor is it characterized as a therapeutic target, biomarker, or disease-associated gene product in current biomedical literature or databases. Most research and data refer to the protein-coding PDCD6IP gene, which encodes programmed cell death 6-interacting protein (ALIX), a regulator of the ESCRT pathway with roles in endocytosis, apoptosis, cell division, and viral budding. However, PDCD6IP-DT itself is not a characterized drug target.
None
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on PDCD6IP divergent transcript (PDCD6IP-DT).